AC
| |
Aisling Capital Management LP13F | |
| Aisling Capital Management LP | |
| Last update 2025-05-13 | 13 Stocks (0 new) |
| Value $288.00 Mil | Turnover 0 % |
Aisling Capital Management LP Top Holdings of 2025-03-31
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBIO | BridgeBio Pharma Inc | 6,068,125 | 209,775.1 | 0% | 72.720 | 0% | 3.200 | +31.11% | +68.33% | 8,770.6 | Biotechnology | |
VRNA | Verona Pharma PLC | 615,352 | 39,068.7 | -44.83% | 13.540 | -8.24% | 0.720 | +65.77% | +125.99% | 8,934.6 | Biotechnology | |
SNDX | Syndax Pharmaceuticals Inc | 1,025,000 | 12,587.0 | 0% | 4.360 | 0% | 1.190 | -21.38% | -22.69% | 879.4 | Biotechnology | |
BCAX | Bicara Therapeutics Inc | 568,919 | 7,413.0 | 0% | 2.570 | 0% | 1.040 | -23.98% | -32.32% | 643.0 | Biotechnology | |
GLUE | Monte Rosa Therapeutics Inc | 1,472,331 | 6,831.6 | 0% | 2.370 | 0% | 2.390 | +11.82% | -14.12% | 366.6 | Biotechnology | |
NUVB | Nuvation Bio Inc | 2,541,009 | 4,472.2 | 0% | 1.550 | 0% | 0.750 | +23.08% | -3.76% | 871.1 | Biotechnology | |
CMPS | Compass Pathways PLC | 1,198,418 | 3,427.5 | +24.25% | 1.190 | +0.23% | 1.280 | +16.08% | +22.22% | 432.3 | Healthcare Providers & Services | |
BMEA | Biomea Fusion Inc | 798,757 | 1,701.3 | 0% | 0.590 | 0% | 2.130 | -10.19% | -52.32% | 105.5 | Biotechnology | |
CALC | CalciMedica Inc | 521,114 | 995.3 | 0% | 0.350 | 0% | 3.730 | +174.51% | +18.64% | 58.7 | Biotechnology | |
ELEV | Elevation Oncology Inc | 2,834,910 | 734.5 | 0% | 0.250 | 0% | 4.790 | -3.64% | -35.12% | 21.6 | Biotechnology |
Aisling Capital Management LP's Historical Top Holdings Breakdowns
Aisling Capital Management LP's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
VRNA | Verona Pharma PLC | 2025-03-31 | Reduce Reduce | -8.24% | 44.81 ($59.82) 69.63 | $104.95 | 75.44% | Reduce -44.83% | 615,352 | -500,000 | |
PSTX | Poseida Therapeutics Inc | 2025-03-31 | Sold Out Sold Out | -3.55% | 9.4 ($9.5) 9.56 | $9.50 | 0% | Sold Out | 0 | -1,043,267 | |
CMPS | Compass Pathways PLC | 2025-03-31 | Add Add | +0.23% | 2.86 ($3.84) 4.99 | $4.62 | 20.31% | Add 24.25% | 1,198,418 | 233,918 | |
VIRX | Viracta Therapeutics Inc | 2025-03-31 | Sold Out Sold Out | -0.02% | 0.01 ($0.08) 0.22 | $0.01 | -87.78% | Sold Out | 0 | -288,571 | |
TECX | Tectonic Therapeutic Inc | 2024-12-31 | Sold Out Sold Out | -0.98% | 29.68 ($42.52) 51.7 | $22.92 | -46.10% | Sold Out | 0 | -84,148 | |
RPHM | Reneo Pharmaceuticals Inc | 2024-12-31 | Sold Out Sold Out | -0.58% | 16.5 ($17.33) 18.2 | $18.20 | 5.02% | Sold Out | 0 | -88,608 | |
OKUR | OnKure Therapeutics Inc | 2024-12-31 | New Buy New Buy | +0.27% | 7.89 ($15) 19.21 | $2.38 | -84.13% | New holding | 88,607 | 88,607 | |
MRKR | Marker Therapeutics Inc | 2024-12-31 | Add Add | +0.01% | 2.49 ($3.55) 4.86 | $1.60 | -54.93% | Add 3.53% | 325,370 | 11,084 | |
BCAX | Bicara Therapeutics Inc | 2024-09-30 | New Buy New Buy | +5.55% | 23.41 ($25.5) 27.07 | $11.79 | -53.76% | New holding | 568,919 | 568,919 | |
TECX | Tectonic Therapeutic Inc | 2024-06-30 | New Buy New Buy | +0.60% | 15.93 ($16.33) 17.01 | $22.92 | 40.36% | New holding | 84,148 | 84,148 |
Aisling Capital Management LP Total Holding History ($B)
Aisling Capital Management LP's Asset Allocation
Aisling Capital Management LP Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
Aisling Capital Management LP's Hypothetical Growth since 2025-03-31
Aisling Capital Management LP's Yearly Returns
| Year | Portfolio % | % | Excess Gain % |
|---|
Aisling Capital Management LP's Holdings Heat Map
Size field:
Aisling Capital Management LP's Holdings Bubble Chart
Aisling Capital Management LP News
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers